Document Type

Patent

Patent Number

US Patent 8,148,340

Patent agency

United States Patent and Trademark Office

Publication Date

4-3-2012

Assignee

The United States of America as represented by the Department of Health and Human Services (Washington, DC, US) ; University of Iowa Research Foundation (Iowa City, IA, US) ; Pfizer Inc. (New York, NY, US)

Application Number

10/888,089

Date Filed

2004-07-09

Total Pages

22 pages

Abstract

Oligonucleotides containing unthylated CpG dinucleotides and therapeutic utilities based on their ability to stimulate an immune response in a subject are disclosed. Also disclosed are therapies for treating diseases associated with immune system activation that are initiated by unthylated CpG dinucleotides in a subject comprising administering to the subject oligonucleotides that do not contain unmethylated CpG sequences (i.e. methylated CpG sequences or no CpG sequence) to outcompete unmethylated CpG nucleic acids for binding. Further disclosed are methylated CpG containing dinucleotides for use antisense therapies or as in vivo hybridization probes, and immunoinhibitory oligonucleotides for use as antiviral therapeutics.

Share

COinS
 

URL

https://ir.uiowa.edu/patents/565